Skip to main content
Clinical Trials/NCT02824835
NCT02824835UnknownNot Applicable

The Effect of the Plant Hormones Strigolactones on Cultures of Dysplastic Colonic Lesions and Cancer

Meir Medical Center0 sites150 target enrollmentStarted: July 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
150
Primary Endpoint
percentage of cells in G2/M arrest after dose-dependent exposure

Study Overview

Brief Summary

The purpose of this study is to determine the effects of the plant hormones strigolactones, on cell cultures of colonic polyps and colorectal cancer.

Detailed Description

Strigolactones have been shown to anti-proliferative and pro-apoptotic effects in cell cultures of breast and prostate origin, partially by down-regulation of cyclin B1 and induction of cell cycle arrest. In this study the investigators intend to take biopsies from benign colonic polyps and cancer tissue, culture intestinal explants and generate immortalized primary cells as a platform to assess the effect of this plant hormone on cell viability, cell mobility, apoptosis and cytoskeleton modifications.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients with positive findings during colonoscopy

Exclusion Criteria

  • Patients below 18 years old
  • Patients who cannot sign a consent form

Outcomes

Primary Outcomes

percentage of cells in G2/M arrest after dose-dependent exposure

Time Frame: 24 hours of exposure to strigolactone

analysis of cell cycle

percentage of cells with reduced viability after dose-dependent exposure

Time Frame: 24 hours of exposure to strigolactone

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

ido laish

MD

Meir Medical Center

Similar Trials